McKune John's Form 4 filing
Pulmonx Corp (LUNG) · filed Mar 5, 2024
- Accession no.
- 0001415889-24-006843
- Filed
- Mar 5, 2024
- Trade date
- Mar 1, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $9.77K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001415889-24-007232 (Mar 7, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McKune JohnCIK 0001650427 | Officer (INTERIM CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | SSaleDisposed | −155 | $9.06 | −$1,404.3 | 48,333 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −254 | $9.06 | −$2,301.24 | 48,079 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −669 | $9.06 | −$6,061.14 | 47,410 | Direct | |
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +14,400 | $0.00 | $0 | 61,810 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +28,800 | $0.00 | $0 | 28,800 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.